Brain Scan Study for Early Parkinson's Disease
Part of Brain & nervous system clinical trials.
This trial uses a special brain scan (PET scan) to look at early changes in people who have early signs of Parkinson's disease. The goal is to learn more about how Parkinson's develops over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old and have been told by your doctor that you have early signs (prodromal) of Parkinson's disease.
- You must be able to give your permission (informed consent) to join the study.
- If you are female and could become pregnant, you must use a very reliable birth control method (like birth control pills or an IUD) from 14 days before to 24 hours after the scan, or you must be postmenopausal or surgically sterile.
- You must not have taken certain medicines (tetrabenazine, methylphenidate, reserpine, or amphetamine-like drugs) in the last month before the scan.
- You cannot have any other major medical or mental health condition that the study doctor thinks might interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to measure tau protein buildup in the brain of people with Parkinson's disease (including those with a LRRK2 gene mutation), Progressive Supranuclear Palsy, or Corticobasal Syndrome. It aims to better understand how tau relates to these conditions.
This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.
This trial uses a special PET scan to see how a new imaging agent (called 11C-M503) travels through the body and brain. It may help researchers better understand brain conditions like Parkinson's disease.
This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.
This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.
This study uses a special PET scan to look at a protein (VMAT2) in the brain that is linked to Parkinson's disease. It helps researchers understand early changes in people with newly diagnosed Parkinson's or those at high risk of developing it.
Hear when a new Prodromal Parkinsons Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.